Vertaling van "use and the risk of myocardial " (Frans → Nederlands) :

(Khader 2003) Khader YS, Rice J, Lefante J, Abueita O. Oral contraceptive use and the risk of myocardial infarction: a metaanalysis. Contraception 2003; 68:11-7
(Khader 2003) Khader YS, Rice J, Lefante J, Abueita O. Oral contraceptive use and the risk of myocardial infarction: a meta-analysis.

(Margolis 2007) Margolis KL, Adami HO, Luo J et al. A prospective study of oral contraceptive use and risk of myocardial
(Margolis 2007) Margolis KL, Adami HO, Luo J et al. A prospective study of oral contraceptive use and risk of myocardial infarction among

myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European prospective Investigation into Cancer and nutrition study (EPIC-Heidelberg).
with myocardial infarction and stroke risk and overall cardiovascular mortality in the Heidelberg cohort of the European prospective Investigation into Cancer and nutrition study (EPIC-Heidelberg).

Review: calcium supplements increase risk for myocardial infarction but not mortality or stroke in adults.
Revieuw: calcium supplements increase risk for myocardial infarction but not mortality or stroke in adults.

Shift work linked to increased risk for myocardial infarction and stroke 13/08/2012
Shift work linked to increased risk for myocardial infarction and stroke 13-08-2012

43 2002 meta analysis yes 1179 Reversible defects in less than 20% of myocardial segments do not significantly alter the risk of perioperative cardiac complications.
41 2002 meta analysis yes 1179 Reversible defects in less than 20% of myocardial segments do not significantly alter the risk of perioperative cardiac complications.

Risk of non-fatal venous thromboembolism in women using oral contraceptives containing
Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone

Oral contraceptive use as a risk factor for premenopausal
Oral contraceptive use as a risk factor for premenopausal breast cancer:

DE - Guidance on risk assessment of nanomaterials use at work 19/06/2012
DE - Guidance on risk assessment of nanomaterials use at work 19-06-2012

(Lidegaard 2011) Lidegaard Ø, Hougaard L, Wessel Skovlund C et al. Risk of venous thromboembolism from use of oral
(Lidegaard 2011) Lidegaard Ø, Hougaard L, Wessel Skovlund C et al. Risk of venous thromboembolism from use of oral contraceptives